Carboxyamidotriazole

[1]Hussain MM, et al. J Clin Oncol. 2003 Dec 1;21 (23) :4356-63.|[2]Mignen O, et al. Carboxyamidotriazole-induced inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells. J Cell Sci. 2005 Dec 1;118 (Pt 23) :5615-23.|[3]Enfissi A, et al. The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell Calcium. 2004 Dec;36 (6) :459-67. |[4]Ju R, et al. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition. Cancer Lett. 2016 Jan 28;370 (2) :232-41.|[5]Faehling M, et al. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J. 2002 Nov;16 (13) :1805-7.|[6]Bonnefond ML, et al. Inhibition of store-operated channels by carboxyamidotriazole sensitizes ovarian carcinoma cells to anti-BclxL strategies through Mcl-1 down-regulation. Oncotarget. 2018 Sep 21;9 (74) :33896-33911.|[7]Alessandro R, et al. Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia. J Cell Physiol. 2008 Apr;215 (1) :111-21.|[8]Lu S, et al. Carboxyamidotriazole exerts anti-inflammatory activity in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-κB and MAPKs pathways. Exp Ther Med. 2020 Aug;20 (2) :1455-1466.|[9]Zhou Y, et al. Carboxyamidotriazole alleviates pannus formation and cartilage erosion in rats with adjuvant arthritis. Heliyon. 2023 Sep 14;9 (9) :e20105.|[10]Chen C, et al. Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1. Naunyn Schmiedebergs Arch Pharmacol. 2017 Apr;390 (4) :423-433. |[11]Chen C, et al. Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis. J Pharmacol Exp Ther. 2017 Aug;362 (2) :219-229. |[12]Shi J, et al. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy. J Immunother Cancer. 2019 Sep 11;7 (1) :246. |[13]Tao Z, et al. Therapeutic effect and mechanism of carboxyamidotriazole on the pulmonary fibrosis of mice induced by bleomycin. Zhonghua Yi Xue Za Zhi. 2018 Feb 27;98 (8) :612-616. Chinese.